Emerging perspectives on glaucoma: Highlights of a roundtable discussion

American Journal of Ophthalmology

Volumn 130, Issue 4 SUPPL. 1, 2000, Pages S1-S11

  Lee, David A ^a,f   Fechtner, Robert D ^b   Fiscella, Richard G ^c   Singh, Kuldev ^d   Stewart, William C ^e  

^a JULES STEIN EYE INSTITUTE   (United States)

^b INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BETOPIC S; BRIMONIDINE; BRINZOLAMIDE; CARBACHOL; CARBASTAT; CARTEOLOL; DEMECARIUM; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; ECOTHIOPATE IODIDE; LATANOPROST; LATANOPROST PLUS TIMOLOL MALEATE; LEVOBUNOLOL; LOPIDINE; MAM; METHAZOLAMIDE; METIPRANOLOL; MIOTIC AGENT; PILOCARPINE; PROSTAGLANDIN; TIMOLOL; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

COST EFFECTIVENESS ANALYSIS; DOCTOR PATIENT RELATION; GLAUCOMA; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

EID: 0033802426     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9394(00)00635-8     Document Type: Review

References (9)

1. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101:515-523.
2. Bloch S, Rosenthal AR, Friedman L, Caldarolla P. Patient compliance in glaucoma. Br J Ophthalmol 1977;61:531-534.
3. Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477-480.
4. Kass MA, Hodapp E, Gordon M, Kolker AE, Goldberg I. Part I. Patient administration of eyedrops: interview. Ann Ophthalmol 1982;14:775-779.
5. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984;6:592-599.
6. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-497.
7. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-1095.
8. Fiscella RG, Geller JL, Gryz LL, Wilensky LL, Viana M. Cost considerations of medical therapy for glaucoma. Am J Ophthalmol 1999;128:426-433.
9. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26:233-236.